Skip to content
TrialScanner

NCT05186324

Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion

No phase registeredCompletedPLXCollaboratorIQVCollaborator

Registry record

Lead sponsor
Chiesi Farmaceutici S.p.A.
Conditions
Fabry Disease
Primary completion
Aug 31, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05186324 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05186324: Fabry Patient's Experience... | TrialScanner